Latest Period
Q4 2025
Security Snapshot
PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share (PPBT) Institutional Ownership
CUSIP: 74638P208
13F Institutional Holders and Ownership History from Q3 2024 to Q1 2026
Institutions Reporting
17
Shares (Excl. Options)
780,508
Price
$0.66
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Ordinary Shares, no par value per share
- Symbol
- PPBT on Nasdaq
- Shares outstanding
- 1,806,796,154
- Price per share
- $0.44
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 780,508
- Total reported value
- $513,183
- % of total 13F portfolios
- 0%
- Share change
- +590,763
- Value change
- +$392,637
- Number of holders
- 17
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- PPBT - PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share is tracked under CUSIP 74638P208.
- 17 institutions reported positions in Q4 2025.
- 4 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 17 to 0 between Q4 2025 and Q1 2026.
- Reported value moved from $513,183 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 17 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 74638P208?
CUSIP 74638P208 identifies PPBT - PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74638P208:
Significant Owners of PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share (PPBT) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| INTRACOASTAL CAPITAL, LLC | 10% | 0% | $113,957,926 | +$34,576,864 | 200,453,695 | +44% | Mitchell P. Kopin | 30 Sep 2025 |
| SUSQUEHANNA SECURITIES, LLC | 5.2% | $63,888,312 | 93,953,400 | Susquehanna Securities, LLC | 31 Dec 2025 | |||
| Lincoln Alternative Strategies LLC | 9.9% | $1,288,650 | 605,000 | Lincoln Alternative Strategies LLC | 04 Sep 2025 | |||
| Orca Capital AG | 4.9% | $652,619 | 306,394 | Orca Capital AG | 04 Sep 2025 |
As of 31 Dec 2025, 17 institutional investors reported holding 780,508 shares of PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share (PPBT). This represents 0.04% of the company’s total 1,806,796,154 outstanding shares.
Institutional Holders of PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share (PPBT) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 0 | $0 | -$1,872 | $0.44 | 0 |
| 2025 Q4 | 780,508 | $513,183 | +$392,637 | $0.66 | 17 |
| 2025 Q3 | 132,491 | $75,781 | +$9,482 | $0.57 | 11 |
| 2025 Q2 | 56,968 | $133,604 | +$12,851 | $2.34 | 10 |
| 2025 Q1 | 50,573 | $134,236 | -$128,880 | $2.66 | 7 |
| 2024 Q4 | 80,346 | $376,821 | -$567,897 | $4.69 | 12 |
| 2024 Q3 | 170,369 | $945,992 | +$925,596 | $5.56 | 9 |